American College of Cardiology

Refinements and innovations enhance safety, effectiveness of therapies for acute coronary syndromes

Published in Surgery Litigation and Law Weekly, April 14th, 2006

Research presented at the American College of Cardiology's 55th Annual Scientific Session offers new insight into the most effective therapies for acute coronary syndromes, atrial fibrillation and heart failure, and sheds light on simple ways to prevent the harmful effects of inflammation in patients who have cardiac surgery.

"Together these studies cover an enormous therapeutic range, but each has the potential to change the day-to-day management of patients with cardiovascular disease," said Matthew R. Wolff, MD, F.A.C.C., University of Wisconsin.

When the final results of The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY)...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly

Source: Surgery Litigation and Law Weekly (2006-04-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry